Valeant Stock Drops Making Allergan Deal Tougher – ValueWalk Premium
valeant pharmaceuticals

Valeant Stock Drops Making Allergan Deal Tougher

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX), a “roll-up” company embroiled in a bitter battle to take over Botox-maker Allergan, Inc. (NYSE:AGN), reported earnings Thursday that showed climbing and strong growth.


Valeant's stock price tumbles after earnings
While the company was making a case to purchase Botox maker Allergan, Inc. (NYSE:AGN), which relies on its stock price as a currency in the acquisition, its saw this stock price tumble after its . . .

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email support@valuewalk.com or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk

Here’s a Tip: Read What Professional Investors Read

ValueWalk Premium is for investors looking to improve their investment process AND keep up-to-date on the latest industry trends.

It’s THE resource for value investing and hedge funds. 📈

And with a free three-day trial and $29.99 per month thereafter, it’s a value in its own right.

Sign up now. 👇

CLICK HERE TO TRY IT OUT

 

0